Lyrica® generic delayed until summer 2019 and Pfizer to increase drug prices

This is a cross-post from our Optum Insights blog. The U.S. Food and Drug Administration’s (FDA) recent decision to grant pediatric exclusivity for Lyrica® ― as it may be used as an adjunctive therapy for partial onset seizures in pediatric epilepsy patients ― extends the period of market exclusivity in the U.S. by an additional … Read moreLyrica® generic delayed until summer 2019 and Pfizer to increase drug prices

Thank You for Your Trust and Confidence in Our Settlement Solutions Team

As we take a couple of days to reflect on our lives, the folks in our lives, and the significance and meaningfulness of those individuals in our lives, on behalf of Optum, I wanted to take this opportunity to say thank you for your trust and confidence in our Settlement Solutions team. We are so … Read moreThank You for Your Trust and Confidence in Our Settlement Solutions Team